AMP Capital Investors Ltd grew its position in shares of AmerisourceBergen Corp. (NYSE:ABC) by 4.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 133,519 shares of the company’s stock after purchasing an additional 6,199 shares during the period. AMP Capital Investors Ltd owned approximately 0.06% of AmerisourceBergen worth $12,260,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Delpha Capital Management LLC bought a new stake in shares of AmerisourceBergen in the fourth quarter worth $137,000. Vantage Investment Advisors LLC bought a new stake in shares of AmerisourceBergen in the fourth quarter worth $156,000. IFG Advisory LLC bought a new stake in shares of AmerisourceBergen in the fourth quarter worth $678,000. TRUE Private Wealth Advisors bought a new stake in shares of AmerisourceBergen in the fourth quarter worth $203,000. Finally, IBM Retirement Fund bought a new stake in shares of AmerisourceBergen in the fourth quarter worth $216,000. Institutional investors own 67.33% of the company’s stock.
In other news, CFO Tim G. Guttman sold 11,600 shares of the business’s stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $93.40, for a total transaction of $1,083,440.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Peyton R. Howell sold 3,000 shares of the business’s stock in a transaction on Wednesday, March 7th. The shares were sold at an average price of $93.78, for a total transaction of $281,340.00. Following the transaction, the insider now directly owns 49,189 shares of the company’s stock, valued at approximately $4,612,944.42. The disclosure for this sale can be found here. In the last quarter, insiders have sold 177,609 shares of company stock valued at $16,855,249. 27.30% of the stock is owned by insiders.
Shares of AmerisourceBergen Corp. (ABC) opened at $100.60 on Wednesday. The company has a current ratio of 0.95, a quick ratio of 0.50 and a debt-to-equity ratio of 1.61. AmerisourceBergen Corp. has a 12 month low of $71.90 and a 12 month high of $106.27. The firm has a market cap of $22,100.00, a price-to-earnings ratio of 57.49, a price-to-earnings-growth ratio of 1.48 and a beta of 1.03.
AmerisourceBergen (NYSE:ABC) last released its earnings results on Tuesday, February 6th. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.35 by $0.20. AmerisourceBergen had a net margin of 0.66% and a return on equity of 53.65%. The firm had revenue of $40.47 billion during the quarter, compared to analyst estimates of $40.42 billion. During the same quarter in the previous year, the firm earned $1.36 earnings per share. The firm’s revenue for the quarter was up 6.0% compared to the same quarter last year. equities research analysts forecast that AmerisourceBergen Corp. will post 6.58 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th were paid a dividend of $0.38 per share. The ex-dividend date of this dividend was Friday, February 16th. This represents a $1.52 annualized dividend and a yield of 1.51%. AmerisourceBergen’s payout ratio is 86.86%.
ILLEGAL ACTIVITY NOTICE: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2018/03/14/amp-capital-investors-ltd-has-12-26-million-stake-in-amerisourcebergen-corp-abc.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.